Indian Clarity

Light. Truth. Clarity.

Loading ad...
Markets

Stocks to buy or sell: From Aurobindo Pharma to UPL— Ajit Mishra of Religare Broking shares strategies for 3 names

Stocks to buy or sell: Indian stock market benchmarks, the Sensex and the Nifty 50, snapped their 4-session losing streak on Thursday, December 4. However, the benchmarks ended with modest gains, while mid- and small-cap indices closed lower, primarily due to the rupee's weakness, foreign capital outflow, and caution ahead of the RBI MPC outcome. The Sensex ended at 85,265.32, rising 159 points, or 0.19%, while the Nifty 50 rose 48 points, or 0.18%, to end at 26,033.75 on Thursday.

Stocks to buy or sell: From Aurobindo Pharma to UPL— Ajit Mishra of Religare Broking shares strategies for 3 names

Credit: Livemint

Key Highlights

  • The BSE Midcap index fell 0.19% while the Smallcap index dropped 0.32%.
  • "Weakness in the rupee continues to pressure sentiment, coupled with caution ahead of the MPC policy outcome.
  • Additionally, mixed global cues failed to spark any meaningful reaction.
  • Going ahead, with the MPC outcome in focus, a 25 bps rate cut appears largely priced in, making the committee’s commentary more crucial for determining the next directional move," said Ajit Mishra, SVP of Research at Religare Broking.
  • Mishra underscored that the Nifty 50 is still holding above its first support zone—the 20 DEMA around 25,950—despite the volatility, aided by renewed buying interest in private banks and IT.
Loading ad...

Sources

  1. Stocks to buy or sell: From Aurobindo Pharma to UPL— Ajit Mishra of Religare Broking shares strategies for 3 names

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

Related Stories

Loading ad...